Patient characteristics
|
% (n)
|
HAD total mean ± SE
|
Treatment factors
|
n (%)
|
HAD total mean ± SE
|
---|
Marital status
| | |
Current Treatment
| | |
Married
|
75.9 (79)
|
13.17 ± 7.87
|
Tamoxifen
|
47.1 (49)
|
13.65 ± 8.30
|
Single
|
24 (25)
|
19.12 ± 10.47
|
Aromatase inhibitors (AI)
|
52.9 (55)
|
15.45 ± 9.37
|
| |
MWU = 704, p = 0.031
| | |
MWU = 1223, p = 0.417
|
Children
| | |
Duration of AET
| | |
One or More
|
82.7 (86)
|
14.36 ± 8.53
|
Between 1 and 24 months
|
49 (51)
|
16.01 ± 9.19
|
None
|
17.3 (18)
|
15.77 ± 10.60
|
Between 25 and 58 months
|
51 (53)
|
13.24 ± 8.45
|
| |
MWU = 761, p = 0.911
| | |
MWU = 1073, p = 0.070
|
Education
| | |
Pathological tumor stage
| | |
Primary or secondary
|
33.7 (35)
|
18.68 ± 9.57
|
T1
|
40.4 (42)
|
15.40 ± 9.28
|
High school
|
32.7 (34)
|
12.38 ± 7.23
|
T2
|
51 (53)
|
14.30 ± 8.83
|
College or above
|
33.7 (35)
|
12.68 ± 8.43
|
T3
|
8.7 (9)
|
12.66 ± 7.77
|
| |
KW = 9.489, p = 0.009
| | |
KW = 0.589, p = 0.745
|
Body mass index
| | |
Histological grade
| | |
≤24.99
|
31.7 (33)
|
12.48 ± 7.12
|
Grade I
|
11.5 (12)
|
12.91 ± 9.11
|
25–29.9
|
40.4 (42)
|
14.33 ± 9.65
|
Grade II
|
49 (51)
|
15.60 ± 8.98
|
≥30
|
27.9 (29)
|
17.41 ± 9.08
|
Grade III
|
39.4 (41)
|
13.85 ± 8.77
|
| |
KW = 4.188, p = 0.123
| | |
KW = 1.750, p = 0.417
|
Menopausal status
| | |
Type of surgery
| | |
Pre-menopausal
|
46.2 (48)
|
13.50 ± 8.43
|
Mastectomy
|
56.7 (59)
|
14.66 ± 8.76
|
Peri or post-menopausal
|
53.8 (56)
|
15.55 ± 9.23
|
Breast conserving surgery
|
43.3 (45)
|
14.53 ± 9.14
|
| |
MWU = 1194, p = 0.329
| | |
MWU = 1308, p = 0.901
|
Socioeconomic status
| | |
Radiotherapy
| | |
Low
|
17.3 (18)
|
16.05 ± 10.11
|
Yes/no
|
71.2 (74)/28.8 (30)
|
14.97 ± 8.97/13.70 ± 8.75
|
Middle
|
70.2 (73)
|
14.24 ± 8.69
| | |
MWU = 1020, p = 0.520
|
High
|
12.5 (13)
|
14.61 ± 8.73
|
Chemotherapy
| | |
| |
KW = 0.512, p = 0.774
|
Yes/no
|
61.5 (64)/38.5 (40)
|
15.21 ± 9.02/13.62 ± 8.69
|
| | | | |
MWU = 1129, p = 0.314
|
-
MWU Mann–Whitney U, KW Kruskall Wallis